The Clatterbridge Cancer Centre and the University of Liverpool have appointed international cancer specialist Professor Michael Brada as Chair of Radiation Oncology, to further strengthen their expertise in pioneering research and cancer treatment.
Professor Michael Brada - who will join the centre on December 2nd from the Royal Marsden Hospital in London - is a world leading researcher who specialises in the treatment of brain, spinal and lung cancers.
He was the first to develop a highly precise method of radiotherapy treatment for tumours of the central nervous system known as fractionated stereotactic conformal radiotherapy, and more recently, he has turned his expertise to developing radiotherapy techniques to treat lung cancers.
Dr Peter Kirkbride, Medical Director at The Clatterbridge Cancer Centre, said: “The professor’s expertise, coupled with The Clatterbridge Cancer Centre and the University of Liverpool’s capabilities in research and clinical trials is set to be a formidable partnership and we all look forward to welcoming Michael.
"His research in the treatment of brain, spine and lung cancers is truly world class, making this a landmark appointment for the region.”
The appointment of Professor Brada comes amidst a series of senior appointments to The Clatterbridge Cancer Centre’s team.
The centre is set to imminently welcome three new clinical directors into post, whilst eight new oncologists and 20 new radiographers have also been appointed, all of whom will be in post by the New Year.
Professor Brada will be joining the Academic Unit of Oncology; a five strong team delivered in partnership with The University of Liverpool which strengthens the close working relationship between the Centre and the University, enabling the region to remain at the forefront of academic practice and pioneering cancer research.
Brada will join leading academics; Professors Dan Palmer, Carlo Palmieri, Philip Johnson and Dr Syed Hussain, who are at the forefront of cancer research in the region.
Dr Peter Kirkbride added: “The Academic Unit of Oncology further tightens our connection to the University of Liverpool and the city as a whole.
"This will put us in great stead to create the new Clatterbridge Cancer Centre site in Liverpool, and will ensure that we remain at the cutting-edge of cancer treatment across the whole region.”
The enhancement of the Academic Unit of Oncology through the appointment of Professor Brada comes as The Clatterbridge Cancer Centre continues to develop plans to build a new site next to the new Royal Liverpool University Hospital and the University of Liverpool.
The new cancer centre, which will offer integrated cancer care right from diagnosis through to discharge, will be the single biggest step towards developing first class services for the region, benefitting people in the Wirral, West Cheshire and north of the Mersey.
For the first time, patients will have access to expert clinical services, surgery, in-patient care, radiotherapy, chemotherapy, critical care, outpatient clinics and enhanced research and development with clinical trials, all on one site.